Coverage of our peer-reviewed research in the healthcare and mainstream press.
In a column for Massachusetts news outlet Melrose Free Press, State Senator Jason Lewis outlined the promises of telemedicine and his goal to pass legislation that would expand access to telehealth services. He cited a 2015 study published in The American Journal of Managed Care® (AJMC®), “Opportunity Costs of Ambulatory Medical Care in the United States,” which found that although medical visits take up an average 2 hours of a patient’s time, only 20 minutes are actually spent face-to-face with a physician. Lewis argued that telemedicine visits can eliminate the time spent traveling to clinics and ideally provide more convenient and accessible care.
A press release from insurer Anthem described its survey published in Benefits Quarterly, which found that 90% of large employers considered the cost of new specialty drugs a challenge. To explain this burden, it referenced a Payer Perspective article titled “The Growing Cost of Specialty Pharmacy: Is it Sustainable?” and published by AJMC® in 2013. This article discussed how the array of specialty drugs on the market had “grown substantially” from 10 in 1990 to nearly 300 in 2012.
There are 3 significant challenges providers face in implementing payments, according to an article on RevCycleIntelligence.com, including the unexpected spending that can arise as a result of complications or nonadherence. It illustrated this point with a quote from a 2016 AJMC® interview, “Dr Joshua Cohen Considers the Cons of Bundled Payments.” “There are situations where using a bundle may be inappropriate because the factors that are influencing differences in cost among patients are things that the provider doesn’t actually control,” Cohen said.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More